Esperion Therapeutics Inc (ESPR)
1.995
-0.04
(-1.72%)
USD |
NASDAQ |
Nov 04, 16:00
2.01
+0.02
(+0.75%)
After-Hours: 20:00
Esperion Therapeutics Market Cap: 391.47M for Nov. 4, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 01, 2024 | 398.34M |
| October 31, 2024 | 400.30M |
| October 30, 2024 | 417.96M |
| October 29, 2024 | 408.15M |
| October 28, 2024 | 417.96M |
| October 25, 2024 | 412.07M |
| October 24, 2024 | 404.22M |
| October 23, 2024 | 402.26M |
| October 22, 2024 | 417.96M |
| October 21, 2024 | 404.22M |
| October 18, 2024 | 400.30M |
| October 17, 2024 | 414.03M |
| October 16, 2024 | 416.00M |
| October 15, 2024 | 417.96M |
| October 14, 2024 | 410.11M |
| October 11, 2024 | 386.56M |
| October 10, 2024 | 370.86M |
| October 09, 2024 | 378.71M |
| October 08, 2024 | 406.19M |
| October 07, 2024 | 400.30M |
| October 04, 2024 | 423.85M |
| October 03, 2024 | 384.60M |
| October 02, 2024 | 357.13M |
| October 01, 2024 | 315.92M |
| September 30, 2024 | 323.77M |
| Date | Value |
|---|---|
| September 27, 2024 | 329.66M |
| September 26, 2024 | 321.81M |
| September 25, 2024 | 315.92M |
| September 24, 2024 | 323.77M |
| September 23, 2024 | 319.85M |
| September 20, 2024 | 329.66M |
| September 19, 2024 | 343.39M |
| September 18, 2024 | 341.43M |
| September 17, 2024 | 349.28M |
| September 16, 2024 | 345.36M |
| September 13, 2024 | 374.79M |
| September 12, 2024 | 343.39M |
| September 11, 2024 | 341.43M |
| September 10, 2024 | 339.47M |
| September 09, 2024 | 333.58M |
| September 06, 2024 | 323.77M |
| September 05, 2024 | 337.51M |
| September 04, 2024 | 357.13M |
| September 03, 2024 | 359.09M |
| August 30, 2024 | 359.09M |
| August 29, 2024 | 343.39M |
| August 28, 2024 | 333.58M |
| August 27, 2024 | 335.54M |
| August 26, 2024 | 345.36M |
| August 23, 2024 | 347.32M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
81.90M
Minimum
Oct 26 2023
2.032B
Maximum
Feb 13 2020
564.09M
Average
436.54M
Median
Market Cap Benchmarks
| Perspective Therapeutics Inc | 816.55M |
| Nektar Therapeutics | 245.75M |
| Alaunos Therapeutics Inc | 3.203M |
| Oragenics Inc | 1.724M |
| Cocrystal Pharma Inc | 19.13M |
Market Cap Related Metrics
| PS Ratio | 1.082 |
| Price | 1.995 |
| Earnings Yield | -43.11% |
| Operating PE Ratio | 60.76 |